Home
/
Immunocore Holdings plc
/
Financials
/
Quarterly
Immunocore Holdings plc — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Immunocore Holdings plc filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Sep 30, 2024
$80.25M
Nov 6, 2024
Q2
2024
Jun 30, 2024
$75.40M
Aug 8, 2024
Q1
2024
Mar 31, 2024
$70.50M
May 8, 2024
Q3
2024
Sep 30, 2023
$64.85M
Nov 6, 2024
Q2
2024
Jun 30, 2023
$59.76M
Aug 8, 2024
Q1
2024
Mar 31, 2023
$54.66M
May 8, 2024
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$103.69M
Nov 6, 2025
Q2
2025
Jun 30, 2025
$97.96M
Aug 7, 2025
Q1
2025
Mar 31, 2025
$93.88M
May 7, 2025
Q3
2025
Sep 30, 2024
$80.25M
Nov 6, 2025
Q2
2025
Jun 30, 2024
$75.40M
Aug 7, 2025
Q1
2025
Mar 31, 2024
$70.50M
May 7, 2025
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($177.0K)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($10.30M)
Aug 7, 2025
Q3
2025
Jun 30, 2025
($10.30M)
Nov 6, 2025
Q1
2025
Mar 31, 2025
$5.02M
May 7, 2025
Q2
2025
Mar 31, 2025
$5.02M
Aug 7, 2025
Q3
2025
Mar 31, 2025
$5.02M
Nov 6, 2025
Q3
2025
Sep 30, 2024
$8.74M
Nov 6, 2025
Q3
2025
Jun 30, 2024
($11.62M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($11.62M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($24.44M)
May 7, 2025
Q2
2025
Mar 31, 2024
($24.44M)
Aug 7, 2025
Q3
2025
Mar 31, 2024
($24.44M)
Nov 6, 2025
Q3
2024
Sep 30, 2023
$906.0K
Nov 6, 2024
Q2
2024
Jun 30, 2023
($17.01M)
Aug 8, 2024
Q3
2024
Jun 30, 2023
($17.01M)
Nov 6, 2024
Q1
2024
Mar 31, 2023
($19.45M)
May 8, 2024
Q3
2024
Mar 31, 2023
($19.45M)
Nov 6, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.17M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($14.88M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($3.62M)
May 7, 2025
Q3
2025
Sep 30, 2024
($8.50M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($16.02M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($26.49M)
May 7, 2025
Q3
2024
Sep 30, 2023
($14.14M)
Nov 6, 2024
Q2
2024
Jun 30, 2023
($13.76M)
Aug 8, 2024
Q1
2024
Mar 31, 2023
($14.70M)
May 8, 2024